Skip to main content
The Egyptian Journal of Internal Medicine
Download PDF

Risk factors of hematological malignancies in Upper Egypt: a case–control study

The Egyptian Journal of Internal Medicine volume 31, pages 171–177 (2019)Cite this article

Abstract

Background

The definite etiologies of hematological malignancies (HMs) are still unknown.

Objective

The aim of our study was to identify the distribution of HMs and its subtypes as well as to determine their risk factors in Assiut Governorate, Upper Egypt.

Patients and methods

This case–control study included 1137 patients diagnosed with different HMs (leukemia, lymphoma, myelodysplastic syndromes, and multiple myeloma) and normal healthy controls from January 2014 to December 2017. Data were collected using interviewed administered questionnaire, and clinical and biochemical assessment. Logistic regression analysis was conducted to identify the predictors of HMs and their subtypes.

Results

Leukemia was the most common presented HM (75%), nearly half of leukemic cases were acute myeloid leukemia, while non-Hodgkin’s represented the majority of patients with lymphoma. Increasing age and diabetes mellitus were significantly associated with all HMs. Except for multiple myeloma, hepatitis C virus and obesity had significantly higher odds ratio for HMs and their subtypes. Exposure to agricultural chemicals was a risk factor for lymphoma and myelodysplastic syndromes while exposure to electromagnetic field was a significant risk factor for leukemia.

Conclusion and recommendations

This is the first study evaluating the different risk factors and distribution of HMs in Upper Egypt. Studies with a more detailed evaluation of the role of the possible risk factors in the occurrence of blood cancers in Egypt are recommended.

References

  1. Hamid GA. The Pattern of Hematological Malignancies at Al-Gamhouria Teaching Hospital, Aden, Yemen, from 2008 to 2010. Turk J Hematol 2012; 29:342–347.

    Google Scholar 

  2. Rodriguez-Abreu D, Bordoni A, Zucca E. Epidemiology of hematological malignancies. Ann Oncol 2007; 18 (Suppl 1):i3–i8.

    PubMed  Google Scholar 

  3. Floderus B, Persson T, Stenlund C, Wennberg A, Ost A, Knave B. Occupational exposure to electromagnetic fields in relation to leukemia and brain tumors: a case-control study in Sweden. Cancer Causes Control 1993; 4:465–476.

    CAS  PubMed  Google Scholar 

  4. Smith A, Howell D, Patmore R, Jack A, Roman E. Incidence of haematological malignancy by sub-type: a report from the Haematological Malignancy Research Network. Br J Cancer 2011; 105:1684–1692.

    CAS  PubMed  PubMed Central  Google Scholar 

  5. Pasqualetti P, Festuccia V, Acitelli P, Collacciani A, Giusti A, Casale R. Tobacco smoking and risk of haematological malignancies in adults: a case-control study. Br J Haematol 1997; 97:659–662.

    CAS  PubMed  Google Scholar 

  6. Lichtman MA. Obesity and the risk for a hematological malignancy: leukemia, lymphoma, or myeloma. Oncologist 2010; 15:1083–1101.

    PubMed  PubMed Central  Google Scholar 

  7. Kedia S, Bhatt VR, Rajan SK, Tandra PK, El Behery RA, Akhtari M. Benign and malignant hematological manifestations of chronic hepatitis C virus infection. Int J Prev Med 2014; 5(Suppl 3):S179–S192.

    PubMed  PubMed Central  Google Scholar 

  8. Rauscher GH, Sandler DP, Poole C, Pankow J, Mitchell B, Bloomfield CD, et al. Family history of cancer and incidence of acute leukemia in adults. Am J Epidemiol 2002; 156:517–526.

    PubMed  Google Scholar 

  9. Pasqualetti P, Casale R, Colantonio D, Collacciani A. Occupational risk for hematological malignancies. Am J Hematol 1991; 38:147–149.

    CAS  PubMed  Google Scholar 

  10. Ibrahim AS, Khaled HM, Mikhail NN, Baraka H, Kamel H. Cancer incidence in Egypt: results of the national population-based cancer registry program. J Cancer Epidemiol 2014; 2014:18.

    Google Scholar 

  11. Herzog C, Dey S, Hablas A, Khaled H, Seifeldin I, Ramadan M. Geographic distribution of hematopoietic cancers in the Nile delta of Egypt. Ann Oncol 2012; 23:2748–2755.

    CAS  PubMed  PubMed Central  Google Scholar 

  12. Rayburn WF. Diagnosis and classification of diabetes mellitus: highlights from the American Diabetes Association. J Reprod Med 1997; 42:585–586.

    CAS  PubMed  Google Scholar 

  13. Consultation W. Obesity: preventing and managing the global epiDEMIC. 2000.

  14. Mohammed ME, Hassan AM, Abdelhadi HA, Elsadig MG, Adam DM, Elmamoun K. Burden and Pattern of Cancer in the Sudan, 2000-2006. 2014.

  15. Hossain MS, Iqbal MS, Khan MA, Rabbani MG, Khatun H, Munira S. Diagnosed hematological malignancies in Bangladesh-a retrospective analysis of over 5000 cases from 10 specialized hospitals. BMC Cancer 2014; 14:438.

    PubMed  PubMed Central  Google Scholar 

  16. Siegel RL, Miller KD, Jemal A. Cancer statistics, 2016. CA Cancer J Clin 2016; 66:7–30.

    PubMed  Google Scholar 

  17. Schonfeld SJ, Erdmann F, Wiggill T, Singh E, Kellett P, Babb C. Hematologic malignancies in South Africa 2000-2006: analysis of data reported to the National Cancer Registry. Cancer Med 2016; 5:728–738.

    PubMed  PubMed Central  Google Scholar 

  18. Babatunde A, Amiwero C, Olatunji P, Durotoye I. Pattern of haematological malignancies in Ilorin, Nigeria: a ten year review. Internet J Hematol 2009; 5:2.

    Google Scholar 

  19. Bron D, Ades L, Fulop T, Goede V, Stauder R. Aging and blood disorders: new perspectives, new challenges. Haematologica 2015; 100:415–417.

    PubMed  PubMed Central  Google Scholar 

  20. Cartwright RA, Gurney KA, Moorman AV. Sex ratios and the risks of haematological malignancies. Br J Haematol 2002; 118:1071–1077.

    PubMed  Google Scholar 

  21. Horesh N, Horowitz NA. Does gender matter in non-Hodgkin lymphoma? Differences in epidemiology, clinical behavior, and therapy. Rambam Maimonides Med J 2014; 5:4.

    Google Scholar 

  22. Sinner PJ, Cerhan JR, Folsom AR, Ross JA. Positive association of farm or rural residence with acute myeloid leukemia incidence in a cohort of older women. Cancer Epidemiol Prev Biomarkers 2005; 14:2446–2448.

    Google Scholar 

  23. Thomas X, Chelghoum Y. Cigarette smoking and acute leukemia. Leuk Lymphoma 2004; 45:1103–1109.

    CAS  PubMed  Google Scholar 

  24. Smoke T. IARC monographs on the evaluation of carcinogenic risks to humans. 1995.

  25. Ugai T, Matsuo K, Sawada N, Iwasaki M, Yamaji T, Shimazu T. Smoking and subsequent risk of leukemia in Japan: The Japan Public Health Center-based Prospective Study. J Epidemiol 2017; 27:305–310.

    PubMed  PubMed Central  Google Scholar 

  26. Musselman JR, Blair CK, Cerhan JR, Nguyen P, Hirsch B, Ross JA. Risk of adult acute and chronic myeloid leukemia with cigarette smoking and cessation. Cancer Epidemiol 2013; 37:410–416.

    PubMed  Google Scholar 

  27. Kasim K, Levallois P, Abdous B, Auger P, Johnson KC. Lifestyle factors and the risk of adult leukemia in Canada. Cancer Causes Control 2005; 16:489–500.

    PubMed  Google Scholar 

  28. Kaufman DW, Anderson TE, Issaragrisil S. Risk factors for leukemia in Thailand. Ann Hematol 2009; 88:1079–1088.

    PubMed  Google Scholar 

  29. Fircanis S, Merriam P, Khan N, Castillo JJ. The relation between cigarette smoking and risk of acute myeloid leukemia: an updated meta-analysis of epidemiological studies. Am J Hematol 2014; 89:8.

    Google Scholar 

  30. Milham Jr S. Mortality from leukemia in workers exposed to electrical and magnetic fields. N Engl J Med 1982; 307:4.

    Google Scholar 

  31. Bethwaite P, Cook A, Kennedy J, Pearce N. Acute leukemia in electrical workers: a New Zealand case-control study. Cancer Causes Control 2001; 12:683–689.

    CAS  PubMed  Google Scholar 

  32. Willett E, McKinney P, Fear N, Cartwright R, Roman E. Occupational exposure to electromagnetic fields and acute leukaemia: analysis of a case-control study. Occup Environ Med 2003; 60:577–583.

    CAS  PubMed  PubMed Central  Google Scholar 

  33. Blair A, White DW. Leukemia cell types and agricultural practices in Nebraska. Arch Environ Health 1985; 40:211–214.

    CAS  PubMed  Google Scholar 

  34. Gold LS, Gold LS, Manley NB, Slone TH, Ward JM. Compendium of chemical carcinogens by target organ: results of chronic bioassays in rats, mice, hamsters, dogs, and monkeys. Toxicol Pathol 2001; 29:639–652.

    CAS  PubMed  Google Scholar 

  35. Blair A, Purdue MP, Weisenburger DD, Baris D. Chemical exposures and risk of chronic lymphocytic leukaemia. Br J Haematol 2007; 139:753–761.

    CAS  PubMed  Google Scholar 

  36. Balasubramaniam G, Saoba SL, Sarhade MN, Kolekar SA. Lifestyle factors including diet and leukemia development: a case-control study from Mumbai, India. Asian Pac J Cancer Prev 2013; 14:5657–5661.

    PubMed  Google Scholar 

  37. Merhi M, Raynal H, Cahuzac E, Vinson F, Cravedi J, Gamet-Payrastre L. Occupational exposure to pesticides and risk of hematopoietic cancers: meta-analysis of case-control studies. Cancer Causes Control 2007; 18:1209–1226.

    CAS  PubMed  Google Scholar 

  38. Li S, Chen L, Jin W, Ma X, Ma Y, Dong F. Influence of body mass index on incidence and prognosis of acute myeloid leukemia and acute promyelocytic leukemia: a meta-analysis. Sci Rep 2017; 7: 17998.

    PubMed  PubMed Central  Google Scholar 

  39. Larsson SC, Wolk A. Overweight and obesity and incidence of leukemia: a meta-analysis of cohort studies. Int J Cancer 2008; 122:1418–1421.

    CAS  PubMed  Google Scholar 

  40. Fietta P, Delsante G, Quaini F. Hematologic manifestations of connective autoimmune diseases. Clin Exp Rheumatol 2009; 27:140–154.

    CAS  PubMed  Google Scholar 

  41. Bernatsky S, Ramsey-Goldman R, Clarke A. Exploring the links between systemic lupus erythematosus and cancer. Rheum Dis Clin 2005; 31:387–402.

    Google Scholar 

  42. Brown LM, Gridley G, Check D, Landgren O. Risk of multiple myeloma and monoclonal gammopathy of undetermined significance among white and black male United States veterans with prior autoimmune, infectious, inflammatory, and allergic disorders. Blood 2008; 111:3388–3394.

    CAS  PubMed  PubMed Central  Google Scholar 

  43. Löfström B, Backlin C, Sundström C, Hellström-Lindberg E, Ekbom A, Lundberg IE. Myeloid leukaemia in systemic lupus erythematosus—a nested case-control study based on Swedish registers. Rheumatology 2009; 48:1222–1226.

    PubMed  Google Scholar 

  44. Anderson LA, Pfeiffer RM, Landgren O, Gadalla S, Berndt SI, Engels EA. Risks of myeloid malignancies in patients with autoimmune conditions. Br J Cancer 2009; 100:822–828.

    CAS  PubMed  PubMed Central  Google Scholar 

  45. Kandeel A, Genedy M, El-Refai S, Funk AL, Fontanet A, Talaat M. The prevalence of hepatitis C virus infection in Egypt 2015: implications for future policy on prevention and treatment. Liver Int 2017; 37:45–53.

    CAS  PubMed  Google Scholar 

  46. Anwar B, Asif N, Hassan K. Haematological malignancies in chronic hepatitis C patients referred for bone marrow biopsy. J Islamabad Med Dent Coll 2013; 2:17–20.

    Google Scholar 

  47. Torres HA, Shigle TL, Hammoudi N, Link JT, Samaniego F, Kaseb A. The oncologic burden of hepatitis C virus infection: a clinical perspective. CA Cancer J Clin 2017; 67:411–431.

    PubMed  PubMed Central  Google Scholar 

  48. Castillo JJ, Mull N, Reagan JL, Nemr S, Mitri J. Increased incidence of non-Hodgkin lymphoma, leukemia, and myeloma in patients with diabetes mellitus type 2: a meta-analysis of observational studies. Blood 2012; 119:4845–4850.

    CAS  PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Clinical Hematology Unit, Department of Internal Medicine, Assiut University, Assiut, 71516, Egypt

    Safinaz Hussein & Rania Hafez MD

  2. Department of Public Health and Community Medicine, Assiut University, Assiut, Egypt

    Doaa Mohamed

Authors
  1. Safinaz Hussein
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Doaa Mohamed
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Rania Hafez MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Rania Hafez MD.

Additional information

This is an open access journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.

Rights and permissions

This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Hussein, S., Mohamed, D. & Hafez, R. Risk factors of hematological malignancies in Upper Egypt: a case–control study. Egypt J Intern Med 31, 171–177 (2019). https://doi.org/10.4103/ejim.ejim_81_18

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.4103/ejim.ejim_81_18

Keywords